Guoqiang Xu

5.3k total citations
159 papers, 4.0k citations indexed

About

Guoqiang Xu is a scholar working on Molecular Biology, Materials Chemistry and Biomedical Engineering. According to data from OpenAlex, Guoqiang Xu has authored 159 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Molecular Biology, 38 papers in Materials Chemistry and 26 papers in Biomedical Engineering. Recurrent topics in Guoqiang Xu's work include Ubiquitin and proteasome pathways (34 papers), Protein Degradation and Inhibitors (19 papers) and Advanced Proteomics Techniques and Applications (14 papers). Guoqiang Xu is often cited by papers focused on Ubiquitin and proteasome pathways (34 papers), Protein Degradation and Inhibitors (19 papers) and Advanced Proteomics Techniques and Applications (14 papers). Guoqiang Xu collaborates with scholars based in China, United States and Canada. Guoqiang Xu's co-authors include Samie R. Jaffrey, Jeremy S. Paige, Zhihong Zhang, Qingming Luo, Wayne L. Mattice, Yuan Qian, Bolei Dai, Sha Qiao, Xiang Yu and Liang Zhou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Advanced Materials.

In The Last Decade

Guoqiang Xu

156 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guoqiang Xu China 31 2.3k 657 645 569 421 159 4.0k
Yubin Zhou United States 45 3.5k 1.5× 606 0.9× 734 1.1× 617 1.1× 350 0.8× 178 6.1k
Kevin J. Yarema United States 43 3.9k 1.7× 515 0.8× 451 0.7× 525 0.9× 147 0.3× 108 5.2k
Dimitri Scholz Germany 32 2.7k 1.2× 336 0.5× 428 0.7× 343 0.6× 225 0.5× 77 4.6k
Shinae Kizaka‐Kondoh Japan 35 2.3k 1.0× 934 1.4× 363 0.6× 784 1.4× 324 0.8× 110 4.4k
М. П. Кирпичников Russia 39 4.2k 1.9× 559 0.9× 434 0.7× 438 0.8× 406 1.0× 435 6.1k
Menotti Ruvo Italy 34 2.0k 0.9× 371 0.6× 493 0.8× 518 0.9× 124 0.3× 179 3.4k
Hiroshi Ueda Japan 37 3.7k 1.6× 828 1.3× 407 0.6× 483 0.8× 302 0.7× 296 5.5k
Jeeva Munasinghe United States 31 1.1k 0.5× 905 1.4× 299 0.5× 293 0.5× 632 1.5× 72 3.4k
Jeong Kon Seo South Korea 25 1.3k 0.6× 458 0.7× 269 0.4× 297 0.5× 415 1.0× 73 2.6k
Patrick B. Dennis United States 22 3.7k 1.6× 244 0.4× 329 0.5× 496 0.9× 238 0.6× 52 5.0k

Countries citing papers authored by Guoqiang Xu

Since Specialization
Citations

This map shows the geographic impact of Guoqiang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoqiang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoqiang Xu more than expected).

Fields of papers citing papers by Guoqiang Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoqiang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoqiang Xu. The network helps show where Guoqiang Xu may publish in the future.

Co-authorship network of co-authors of Guoqiang Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Guoqiang Xu. A scholar is included among the top collaborators of Guoqiang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoqiang Xu. Guoqiang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Dan, et al.. (2025). The histone demethylase KDM5C enhances the sensitivity of acute myeloid leukemia cells to lenalidomide by stabilizing cereblon. Cellular & Molecular Biology Letters. 30(1). 14–14. 1 indexed citations
2.
Peng, Shuai, Xin Liu, Haibo Wang, et al.. (2024). Efficient Chemical Synthesis of Multi-Monoubiquitylated and Diubiquitylated Histones by the α-Halogen Ketone-Mediated Strategy. Bioconjugate Chemistry. 35(7). 944–953. 1 indexed citations
3.
Wang, Meng, et al.. (2024). Constructing a narrow band gap ZnIn2S4/Fe2O3 Z-scheme heterojunction for improving degradation activity of atrazine and methylene blue. Materials Science in Semiconductor Processing. 175. 108290–108290. 5 indexed citations
4.
Xiao, Mingyue, Kexin Wang, Suya Sun, et al.. (2023). Ephrin B3 exacerbates colitis and colitis-associated colorectal cancer. Biochemical Pharmacology. 220. 116004–116004. 1 indexed citations
5.
Zhang, Jie, Xinhua Li, Gen Li, et al.. (2023). PDLIM3 supports hedgehog signaling in medulloblastoma by facilitating cilia formation. Cell Death and Differentiation. 30(5). 1198–1210. 9 indexed citations
6.
Wang, Xiaohui, et al.. (2023). The fine-tuned crosstalk between lysine acetylation and the circadian rhythm. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1866(3). 194958–194958. 2 indexed citations
7.
Shi, Rui, Peichen Pan, Rui Lv, et al.. (2022). High-throughput glycolytic inhibitor discovery targeting glioblastoma by graphite dots–assisted LDI mass spectrometry. Science Advances. 8(7). eabl4923–eabl4923. 26 indexed citations
8.
Lin, Yu, Kexin Wang, Yanlin Zhang, et al.. (2022). Hederacoside C ameliorates colitis via restoring impaired intestinal barrier through moderating S100A9/MAPK and neutrophil recruitment inactivation. Acta Pharmacologica Sinica. 44(1). 105–119. 20 indexed citations
9.
Zhuang, Haixia, Ying Ren, Chenyu Mao, et al.. (2022). Induction of zinc finger protein RNF6 auto-ubiquitination for the treatment of myeloma and chronic myeloid leukemia. Journal of Biological Chemistry. 298(9). 102314–102314. 10 indexed citations
10.
Liu, Hongxian, Xin Zhao, Yu Zhou, et al.. (2021). Single-cell RNA sequencing reveals thatBMPR2mutation regulates right ventricular functionvia IDgenes. European Respiratory Journal. 60(1). 2100327–2100327. 6 indexed citations
11.
Ullah, Kifayat, Suping Chen, Jiaqi Lü, et al.. (2020). The E3 ubiquitin ligase STUB1 attenuates cell senescence by promoting the ubiquitination and degradation of the core circadian regulator BMAL1. Journal of Biological Chemistry. 295(14). 4696–4708. 47 indexed citations
14.
Ullah, Kifayat, et al.. (2018). Diverse roles of the E2/E3 hybrid enzyme UBE2O in the regulation of protein ubiquitination, cellular functions, and disease onset. FEBS Journal. 286(11). 2018–2034. 39 indexed citations
15.
Zhu, Ying, Qing Lei, Dan Li, et al.. (2018). Proteomic and Biochemical Analyses Reveal a Novel Mechanism for Promoting Protein Ubiquitination and Degradation by UFBP1, a Key Component of Ufmylation. Journal of Proteome Research. 17(4). 1509–1520. 19 indexed citations
16.
Li, Jia, Chengbing Wang, Chuanqing Wu, et al.. (2017). PKA-mediated Gli2 and Gli3 phosphorylation is inhibited by Hedgehog signaling in cilia and reduced in Talpid3 mutant. Developmental Biology. 429(1). 147–157. 23 indexed citations
17.
Zhang, Zhaolei, Lei Zhou, Yanqing Zhou, et al.. (2015). Mitophagy induced by nanoparticle–peptide conjugates enabling an alternative intracellular trafficking route. Biomaterials. 65. 56–65. 41 indexed citations
18.
Xu, Guoqiang, Jeremy S. Paige, & Samie R. Jaffrey. (2010). Global analysis of lysine ubiquitination by ubiquitin remnant immunoaffinity profiling. Nature Biotechnology. 28(8). 868–873. 433 indexed citations
19.
Narayan, Mahesh, et al.. (2008). Dissimilarity in the oxidative folding of onconase and ribonuclease A, two structural homologues. Protein Engineering Design and Selection. 21(4). 223–231. 10 indexed citations
20.
Ye, Chun, Guoqiang Xu, Zhen‐Qiang Yu, et al.. (2005). Frustrated Molecular Packing in Highly Ordered Smectic Phase of Side-Chain Liquid Crystalline Polymer with Rigid Polyacetylene Backbone. Journal of the American Chemical Society. 127(21). 7668–7669. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026